Whether you're a newly minted MBA or an experienced leader, you're always honing your skills and navigating change. And technology is one discipline in which you really can't afford to stagnate.
Business intelligence tools allow a company to parse through its data to find the bits most important to its operations. Maybe that means figuring out which carrier is letting it down (or conversely, for a carrier to see if a shipper is unprofitable for it to serve). Maybe it just means going through visibility data to determine whether a perceived chokepoint is actually a problem.
Chinese companies now account for more than 50 percent of the global active pharmaceutical ingredient (API) market. It has more than 500 companies registered to sell in the U.S. and 10 times that many serving its own market. But many of those continue to struggle to meet international standards.
It's deja vu for the pharma industry. Mylan's EpiPen pricing controversy - kicked into high gear with mainstream media coverage of widespread outrage - has revived public and political fury against drug companies.
The holiday season is a make or break scramble for retailers. Their offices are busy and everyone is in a high stress mode to make the season profitable. They invest in getting people in their stores or on their sites with attractive offers. Unfortunately, this omnichannel approach has given way to increase "out-of-stock" challenges.
Automakers embraced Takata's cheaper technology almost 20 years ago despite signs that it was unsafe. The airbags are now at the center of the auto industry's biggest recall.
Globally and in the U.S., a new breed of company - including manufacturers - are taking advantage of growth outside their home market and going international. To what extent are small and middle market businesses becoming more multinational? What's driving this trend?